Dexpramipexole Renal PK Study

NCT01424176 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis
Renal Insufficiency

Interventions

DRUG: Dexpramipexole (dose 1)
DRUG: Dexpramipexole (dose 2)

Sponsor

Knopp Biosciences